Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat-dose intravenous GSK679586 in severe asthma
2008-004149-27Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in severe asthma and asthma comparing GSK679586 arm with Placebo arm (2 arms). Primary endpoint: Change from baseline in Asthma Control Questionnaire (ACQ-7). Started Nov 2008; status: completed.
02
Drugs
gsk679586
03
Conditions
severe asthmaasthma
Beyond the preview
Go deeper on 2008-004149-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004149-27.